三元生物：2025年半年度归属于上市公司股东的净利润同比增长10.73%

Core Viewpoint - San Yuan Bio reported a decline in operating revenue for the first half of 2025, while net profit showed an increase, indicating mixed financial performance [1] Financial Performance - The company achieved operating revenue of 317,965,979.00 yuan for the first half of 2025, representing a year-on-year decrease of 15.62% [1] - The net profit attributable to shareholders of the listed company was 57,481,930.48 yuan, reflecting a year-on-year increase of 10.73% [1]